Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US
Dabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal, Revlon, Luster Products and Avion Industries among others.
Advertisement
Bengaluru: Dabur India said on Wednesday a U.S. court had dismissed two of its three subsidiaries as defendants in a lawsuit tying the use of hair relaxer products to ovarian and uterine cancers as well as other health issues.
Dermoviva Skin Essentials and Dabur International have been dismissed as defendants "for lack of personal jurisdiction" as neither was involved in manufacturing, marketing, distributing or selling hair relaxer products in the United States, the company said in a late filing on Wednesday.
However, Dabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal , Revlon, Luster Products and Avion Industries among others, it added.
About 5,400 cases against several companies, including Dabur's subsidiaries, were consolidated in multi-district litigation before a U.S. District Court in Illinois, Dabur said last month, after thousands of women, mostly Black women, claimed hair relaxers gave them cancer.
The dismissal, however, comes days after a lawyer representing Dabur and Namaste told Reuters that plaintiffs may not be able to show that Namaste hair relaxer products caused the alleged injuries.
Sales of hair relaxer products by Namaste account for less than 1% of the total consolidated turnover of Dabur India, the parent company said, adding that neither does the lawsuit concern any of its brands nor is Dabur a party to it.
The Vatika shampoo maker also said Namaste denies any liability and has a product liability insurance cover in place for any potential damage and defense cost.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.